5 Ways Doctors Diagnose Alzheimer’s
By
Susanna Granieri
| July 29th, 2020
Alzheimer’s disease affects one in 10 people over the age of 65, but testing for a definitive diagnosis is difficult. As of now, no…
First FDA-Approved Diagnostic Agent to Detect Tau Tangles in Alzheimer’s Patients
By
Amy Yeung
| July 27th, 2020
Scanning technology is the most definitive way of diagnosing Alzheimer’s disease. One of the most accurate is called a positron emission tomography (PET) scan,…
Is Losing Your Sense of Smell a Sign of Dementia? Study Reveals New Clues
By
Deborah Kan
| July 20th, 2020
As we age, so do our abilities to see and hear… Now, new research indicates that out of all of our senses, our sense…
Meet BACE2, a Gene That Can Naturally Suppress Alzheimer’s
By
Alexandra Marvar
| July 13th, 2020
Can a gene that naturally suppresses Alzheimer’s in brain cells pave the way to curing it? In 2012, excitement rippled through the scientific community…
This Discovery May Speed Up Alzheimer’s Drug Testing
By
Alexandra Marvar
| July 9th, 2020
Alzheimer’s clinical trials may take decades, but a new discovery could cut clinical trial time down to a matter of weeks. For nearly a century,…
Viruses, Bacteria Change Our Brains. What Could That Say About Alzheimer’s?
By
Nicholas Chan
| June 24th, 2020
Almost 30 years ago, a small faction of Alzheimer’s researchers proposed the infectious theory of Alzheimer’s — the idea that viruses or bacteria may…
Study: ApoE4 Damages Protective Barrier of the Brain
By
Nicholas Chan
| June 10th, 2020
It was never clear to researchers whether the ApoE4 gene was responsible for the early malfunction of the blood-brain barrier, a protective barrier shielding…
A Mouse Study on Glucose Levels in the Brain Could Hold a Clue to Alzheimer’s
By
Nicholas Chan
| June 5th, 2020
Years of study into the Alzheimer’s biomarker named beta-amyloid have yielded few notable results for an earlier diagnosis and drug treatment. As one alternative,…
Cancer Drug Nilotinib Shows Promise for Treatment of Alzheimer’s
By
Alexandra Marvar
| May 29th, 2020
“We are looking for older volunteers with MCI or mild dementia due to AD or Lewy body dementia, and healthy older individuals, who wish…
An Affordable Blood Test for Alzheimer’s on the Horizon — Five Years Away
By
Alexandra Marvar
| May 21st, 2020
In studies, blood tests to detect Alzheimer’s are showing promise: over the course of years of testing, they are proving to be accurate means…
A Closer Look At How Viruses May Spur Alzheimer’s
By
Alexandra Marvar
| May 6th, 2020
A 2018 study found that herpes is linked to half of all Alzheimer’s cases, but it wasn’t clear why. Then, a year ago, a…
Study: Mild Behavioral Impairment Can Help Predict Alzheimer’s
By
Nicholas Chan
| April 21st, 2020
In the late 1890s, a railroad worker in Frankfurt Germany noticed that his wife, Auguste Deter, was behaving oddly. Gradually her anxiety and mood…
New Genetic Variant Discovered to Protect Against Risk of Alzheimer’s Gene ApoE4
By
Nicholas Chan
| April 17th, 2020
The Alzheimer’s gene, known as ApoE4, is one of the the largest genetic risk factors for later onset Alzheimer’s disease. Carrying one copy of the…
Largest Alzheimer’s Study on Protein Networks Reveals Possible New Biomarker
By
Nicholas Chan
| April 16th, 2020
For decades, researchers have been searching for ways to combat the abnormal proteins that appear in the brains of people with Alzheimer’s. Despite their best…
‘A4’ Study Aims Targets Amyloid in Alzheimer’s Earliest Stages
By
Lecia Bushak
| April 8th, 2020
Targeting beta-amyloid protein before symptoms of cognitive decline or Alzheimer’s appear is the goal of one trial out of the National Institute on Aging…